Literature DB >> 8299568

Characterization of the mitogen-activated protein kinase/90-kilodalton ribosomal protein S6 kinase signaling pathway in 3T3-L1 adipocytes and its role in insulin-stimulated glucose transport.

D C Fingar1, M J Birnbaum.   

Abstract

Insulin exerts diverse effects on mitogenesis, metabolism, gene expression, and protein synthesis depending on the target cell type. A variety of extracellular serine/threonine kinases, including the ribosomal protein S6 kinases pp70-ribosomal S6 kinase (pp70-S6K) and pp90-ribosomal S6 kinase (pp90rsk) and the erk-encoded mitogen-activated protein (MAP) kinases pp44mapk/ERK-1 and pp42mapk/ERK-2, have been postulated as mediators of insulin action. In this study, we have investigated the role of the MAP kinase/pp90rsk signaling pathway in insulin-stimulated glucose transport in 3T3-L1 adipocytes. Differentiation of 3T3-L1 fibroblasts into adipocyte-like cells was accompanied by a marked increase in the capacity of insulin to activate pp90rsk and pp44mapk. Whereas the maximal insulin-stimulated pp90rsk and pp44mapk activities were only approximately 30% of the serum-stimulated activities in preadipocytes, the insulin-stimulated kinase activities in adipocytes were equal to or greater than the serum-stimulated activities. The increase in hormone receptor number accompanying differentiation accounted for the greater sensitivity, as overexpression of human insulin receptors in NIH-3T3 cells also conferred insulin-stimulatable kinase activity. In 3T3-L1 adipocytes, the stimulation of pp90rsk and pp44mapk activities was sufficiently rapid and hormone sensitive to convey a signal for increased hexose uptake. However, epidermal growth factor and fetal bovine serum were equipotent with insulin in stimulating pp90rsk and pp44mapk activities in adipocytes, but were without effect on hexose uptake. These data indicate that activation of these enzymes is not sufficient for the acute stimulation of glucose transport.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8299568     DOI: 10.1210/endo.134.2.8299568

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  7 in total

1.  Alterations in insulin signalling pathway induced by prolonged insulin treatment of 3T3-L1 adipocytes.

Authors:  J M Ricort; J F Tanti; E Van Obberghen; Y Le Marchand-Brustel
Journal:  Diabetologia       Date:  1995-10       Impact factor: 10.122

Review 2.  Insulin regulation of the Ras activation/inactivation cycle.

Authors:  B P Ceresa; J E Pessin
Journal:  Mol Cell Biochem       Date:  1998-05       Impact factor: 3.396

3.  Stimulation of C2C12 myoblast growth by basic fibroblast growth factor and insulin-like growth factor 1 can occur via mitogen-activated protein kinase-dependent and -independent pathways.

Authors:  D J Milasincic; M R Calera; S R Farmer; P F Pilch
Journal:  Mol Cell Biol       Date:  1996-11       Impact factor: 4.272

4.  Mitogenic signals and transforming potential of Nyk, a newly identified neural cell adhesion molecule-related receptor tyrosine kinase.

Authors:  L Ling; H J Kung
Journal:  Mol Cell Biol       Date:  1995-12       Impact factor: 4.272

5.  Allele-specific differential expression of a common adiponectin gene polymorphism related to obesity.

Authors:  Wei-Shiung Yang; Pei-Ling Tsou; Wei-Jei Lee; Da-Lun Tseng; Chi-Ling Chen; Chi-Chung Peng; Kuan-Ching Lee; Mei-Ju Chen; Chang-Jen Huang; Tong-Yuan Tai; Lee-Ming Chuang
Journal:  J Mol Med (Berl)       Date:  2003-05-16       Impact factor: 4.599

6.  Multiple signalling pathways involved in the stimulation of fatty acid and glycogen synthesis by insulin in rat epididymal fat cells.

Authors:  S K Moule; N J Edgell; G I Welsh; T A Diggle; E J Foulstone; K J Heesom; C G Proud; R M Denton
Journal:  Biochem J       Date:  1995-10-15       Impact factor: 3.857

7.  Insulin stimulates the tyrosine phosphorylation of caveolin.

Authors:  C C Mastick; M J Brady; A R Saltiel
Journal:  J Cell Biol       Date:  1995-06       Impact factor: 10.539

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.